Table 1. Demographic and baseline characteristics.
| Study 101 (N=14) | Study 102 (N=27) | |
|---|---|---|
|
Age | ||
| Median age, years (range) | 62 (55–86) | 62 (31–78) |
|
Gender | ||
| Male, n (%) | 9 (64) | 11 (41) |
|
KPS,
n
(%) | ||
| ⩽80% | 6 (43) | 8 (30) |
| ⩾90% | 8 (57) | 19 (70) |
|
Primary tumour type,
n
(%) | ||
| Colorectal | 5 (36) | 8 (30) |
| Pancreatic | 2 (14) | 5 (19) |
| Cholangiocarcinoma | 0 | 3 (11) |
| Pulmonary | 1 (7) | 3 (11) |
| Oesophageal | 0 | 2 (7) |
| Prostate | 3 (21) | 0 |
| Other | 3 (21)a | 6 (22)b |
|
Number of prior systemic therapies | ||
| Median (range) | 4.5 (2–16) | 4 (1–11) |
Abbreviation: KPS=Karnofsky Performance Status score.
a
Ovarian, bladder, sarcoma (n=1 each).
b
Tonsillar, giant cell, ovarian, gastrointestinal carcinoid, gall bladder, adrenal (n=1 each).